Roche Cobas influenza A/B/respiratory fusion virus nucleic acid reagent - Taiwan Registration d1dd1d6a00f7f328d6f6eb061d0a56f6
Access comprehensive regulatory information for Roche Cobas influenza A/B/respiratory fusion virus nucleic acid reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d1dd1d6a00f7f328d6f6eb061d0a56f6 and manufactured by Roche Molecular Systems, Inc.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is suitable for Cobas Liat System, which uses automated multiplex real-time reverse transcription polymerase chain reaction in nasopharyngeal swab samples of patients with signs and symptoms of respiratory infection to qualitatively detect and distinguish between influenza A, B and respiratory fusion virus (RNA of RSV, test results), and should be evaluated in combination with clinical and epidemiological risk factors.
C Immunology and Microbiology; A Clinical chemistry and clinical toxicology
C.3980 Nucleic acid test for respiratory viruses; A.1660 Quality control materials (analytical and non-analytical)
import
Dates and Status
May 25, 2018
May 25, 2023